Tricia H. Smith, Ph.D.
Affiliations: | 2009 | Pharmacology & Toxicology | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Pharmacology, Molecular BiologyGoogle:
"Tricia Smith"Parents
Sign in to add mentorDana E. Selley | grad student | 2009 | VCU | |
(Effects of cannabinoid receptor interacting protein (CRIP1a) on cannabinoid (CB1) receptor function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Smith TH, Blume LC, Straiker A, et al. (2015) Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. Molecular Pharmacology. 87: 747-65 |
Ngwainmbi J, De DD, Smith TH, et al. (2014) Effects of HIV-1 Tat on enteric neuropathogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14243-51 |
Smith TH, Ngwainmbi J, Hashimoto A, et al. (2014) Morphine dependence in single enteric neurons from the mouse colon requires deletion of β-arrestin2. Physiological Reports. 2 |
Smith TH, Grider JR, Dewey WL, et al. (2013) Correction: Morphine decreases enteric neuron excitability via inhibition of sodium channels (PLoS ONE) Plos One. 8 |
Smith TH, Grider JR, Dewey WL, et al. (2012) Morphine decreases enteric neuron excitability via inhibition of sodium channels. Plos One. 7: e45251 |
Kang M, Maguma HT, Smith TH, et al. (2012) The role of β-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract. The Journal of Pharmacology and Experimental Therapeutics. 340: 567-76 |
Smith TH, Sim-Selley LJ, Selley DE. (2010) Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? British Journal of Pharmacology. 160: 454-66 |
Falenski KW, Thorpe AJ, Schlosburg JE, et al. (2010) FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1775-87 |